Jefferies Starts Immunitybio Inc (IBRX) at Buy
Tweet
Share
E-mailGet Alerts IBRX Hot Sheet
Price: $7.22 +0.28%
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 26
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 26
Join SI Premium – FREE
Jefferies analyst Kelly Shi initiates coverage on Immunitybio Inc (NASDAQ: IBRX) with a Buy rating and a price target of $8.00.
For an analyst ratings summary and ratings history on Immunitybio Inc click here. For more ratings news on Immunitybio Inc click here.
Shares of Immunitybio Inc closed at $3.73 yesterday.
You May Also Be Interested In
- BofA Securities Resumes Williams-Sonoma (WSM) at Buy
- Piper Sandler Assumes Cass Information Systems, Inc. (CASS) at Neutral
- Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
